FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lolkje de Jong van den Berg

Research Profile

Geographic Areas

Netherlands

Concepts & Ideas

Physiology

Pregnancy

Chemicals & Drugs

Living Beings

Newborn Infant

Disorders

Procedures

Activities & Behaviors

Organizations

Pharmacies

Occupations

Pharmacoepidemiology

Co-author Network

Publications

TOP 3
Job F M van Boven; Lolkje T W de Jong van den Berg; Stefan Vegter
Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis.
Priscilla A Zetstra-van der Woude; J Sebastiaan Vroegop; H Jens Bos; Lolkje T W de Jong van den Berg
A population analysis of prescriptions for asthma medications during pregnancy.
Ineke Crijns; Aukje Mantel-Teeuwisse; Eldridge Pinas; Sabine Straus; Rudi Bloemberg; Lolkje T W de Jong van den Berg
Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lolkje de Jong van den Berg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Job F M van Boven; Lolkje T W de Jong van den Berg; Stefan Vegter
Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis.
Drug safety : an international journal of medical toxicology and drug experience 2013;36(4):231-6.
2013: Priscilla A Zetstra-van der Woude; J Sebastiaan Vroegop; H Jens Bos; Lolkje T W de Jong van den Berg
A population analysis of prescriptions for asthma medications during pregnancy.
The Journal of allergy and clinical immunology 2013;131(3):711-7.
2013: Ineke Crijns; Aukje Mantel-Teeuwisse; Eldridge Pinas; Sabine Straus; Rudi Bloemberg; Lolkje T W de Jong van den Berg
Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.
Expert opinion on drug safety 2013;12(1):29-38.
2012: Maarten J Bijlsma; Jens H J Bos; Lolkje T W de Jong van den Berg; Eelko Hak; Fanny Janssen
Inclusion of the birth cohort dimension improved description and explanation of trends in statin use.
Journal of clinical epidemiology 2012;65(10):1052-60.
2012: Hubertina J M J Crijns; Christine C Gispen-de Wied; Sabine M J M Straus; Nienke van Rein; Lolkje T W de Jong van den Berg
Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study.
Pharmacoepidemiology and drug safety 2012;21(10):1060-6.
2012: Petra C Koopmans; Jens H J Bos; Lolkje T W de Jong van den Berg
Are antibiotics related to oral combination contraceptive failures in the Netherlands? A case-crossover study.
Pharmacoepidemiology and drug safety 2012;21(8):865-71.
2012: Ineke Crijns; Marissa Knol; Sabine Straus; Jens Bos; Lolkje T W de Jong van den Berg
Paternal drug use: before and during pregnancy.
Expert opinion on drug safety 2012;11(4):513-8.
2012: Geertruida H de Bock; Marian J E Mourits; Regina F Musters; Caroline P Schröder; H Jens Bos; Lolkje T W de Jong van den Berg
Psychotropic medication during endocrine treatment for breast cancer.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(7):1533-40.
2012: Silvia Ravera; Nienke van Rein; Johan J de Gier; Lolkje T W de Jong van den Berg
A comparison of pharmacoepidemiological study designs in medication use and traffic safety research.
European journal of epidemiology 2012;27(6):473-81.
2012: Josta de Jong; Jens H J Bos; Tjalling W de Vries; Lolkje T W de Jong van den Berg
Antibiotic use in children and the use of medicines by parents.
Archives of disease in childhood 2012;97(6):578-81.
2012: Silvia Ravera; Lolkje T W de Jong van den Berg; Johannes G Ramaekers; Johan J de Gier
Are selective serotonin reuptake inhibitors safe for drivers? What is the evidence?
Clinical therapeutics 2012;34(5):1070-83.
2012: Priscilla A Zetstra-van der Woude; Hermien E K de Walle; Lolkje T W de Jong van den Berg
Periconceptional folic acid use: still room to improve.
Birth defects research. Part A, Clinical and molecular teratology 2012;94(2):96-101.
2012: Janneke Jentink; Cornelis Boersma; Lolkje T W de Jong van den Berg; Maarten J Postma
Economic evaluation of anti-epileptic drug therapies with specific focus on teratogenic outcomes.
Journal of medical economics 2012;15(5):862-8.
2012: Hao Wang; Jens H J Bos; Lolkje T W de Jong van den Berg
Co-prescription of antiepileptic drugs and contraceptives.
Contraception 2012;85(1):28-31.
2011: Janneke Jentink; A Priscilla Zetstra-van der Woude; Jens Bos; Lolkje T W de Jong van den Berg
Evaluation of the representativeness of a Dutch non-malformed control group for the general pregnant population: are these controls useful for EUROCAT?
Pharmacoepidemiology and drug safety 2011;20(11):1217-23.
2011: Stefan Vegter; Sipke T Visser; Lolkje T W de Jong van den Berg; Nhu Ho Nguyen; Maarten J Postma; Cornelis Boersma
Compliance, persistence, and switching patterns for ACE inhibitors and ARBs.
The American journal of managed care 2011;17(9):609-16.
2011: Hubertina J M J Crijns; Lolkje T W de Jong van den Berg; Ester Garne; Christine C Gispen-de Wied; Janneke Jentink; Sabine M J M Straus
The distribution of congenital anomalies within the VACTERL association among tumor necrosis factor antagonist-exposed pregnancies is similar to the general population.
The Journal of rheumatology 2011;38(9):1871-4.
2011: Silvia Ravera; Nienke van Rein; Johan J de Gier; Lolkje T W de Jong van den Berg
Road traffic accidents and psychotropic medication use in The Netherlands: a case-control study.
British journal of clinical pharmacology 2011;72(3):505-13.
2011: Sengwee Toh; Allen A Mitchell; Marlene Anderka; Lolkje T W de Jong van den Berg; Sonia Hernández-Díaz
Antibiotics and oral contraceptive failure - a case-crossover study.
Contraception 2011;83(5):418-25.
2011: Margery Morgan; Lolkje T W de Jong van den Berg; Sue Jordan
Drug safety in pregnancy--monitoring congenital anomalies.
Journal of nursing management 2011;19(3):305-10.
2011: Josta de Jong; Jens H J Bos; Tjalling W de Vries; Lolkje T W de Jong van den Berg
Could adverse reactions of antibiotic drugs in children be detected in a prescription database?
Pharmacoepidemiology and drug safety 2011;20(3):300-3.
2010: Silvia Ravera; Sipke T Visser; Johan J de Gier; Lolkje T W de Jong van den Berg
Prevalence, cumulative incidence, monotherapy and combination therapy, and treatment duration of frequently prescribed psychoactive medications in the Netherlands: retrospective database analysis for the years 2000 to 2005.
Clinical therapeutics 2010;32(14):2457-66.
2010: Annemieke Roos; Thera P Links; Lolkje T W de Jong van den Berg; Rijk O B Gans; Bruce H R Wolffenbuttel; Stephan J L Bakker
Thyroid peroxidase antibodies, levels of thyroid stimulating hormone and development of hypothyroidism in euthyroid subjects.
European journal of internal medicine 2010;21(6):555-9.
2010: Janneke Jentink; Marian K Bakker; Cynthia M Nijenhuis; Bob Wilffert; Lolkje T W de Jong van den Berg
Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
Pharmacoepidemiology and drug safety 2010;19(8):803-7.
2010: Marleen van Gelder; Iris A L M van Rooij; Richard K Miller; Gerhard A Zielhuis; Lolkje T W de Jong van den Berg; Nel Roeleveld
Teratogenic mechanisms of medical drugs.
Human reproduction update 2010;16(4):378-94.
2010: Janneke Jentink; Maria A Loane; Helen Dolk; Ingeborg Barisic; Ester Garne; Joan K Morris; Lolkje T W de Jong van den Berg
Valproic acid monotherapy in pregnancy and major congenital malformations.
The New England journal of medicine 2010;362(23):2185-93.
2010: Cornelis Boersma; Ron T Gansevoort; Petros Pechlivanoglou; Sipke T Visser; Flip F J van Toly; Lolkje T W de Jong van den Berg; Paul E de Jong; Maarten J Postma
Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
Clinical therapeutics 2010;32(6):1103-21.
2010: Tjalling W de Vries; Paul B van den Berg; Eric J Duiverman; Lolkje T W de Jong van den Berg
Effect of a minimal pharmacy intervention on improvement of adherence to asthma guidelines.
Archives of disease in childhood 2010;95(4):302-4.
2010: Stefan Vegter; Lolkje T W de Jong van den Berg
Misdiagnosis and mistreatment of a common side-effect--angiotensin-converting enzyme inhibitor-induced cough.
British journal of clinical pharmacology 2010;69(2):200-3.
2010: Marian K Bakker; Wilhelmina S Kerstjens-Frederikse; Charles H C M Buys; Hermien E K de Walle; Lolkje T W de Jong van den Berg
First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.
Birth defects research. Part A, Clinical and molecular teratology 2010;88(2):94-100.
2010: Adrianne Faber; Luuk J Kalverdijk; Lolkje T W de Jong van den Berg; Jacqueline G Hugtenburg; Ruud B Minderaa; Hilde Tobi
Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands.
European child & adolescent psychiatry 2010;19(2):159-66.
2010: Hong Anh T Tu; Jens H J Bos; Herman J Woerdenbag; Sipke T Visser; Jan C Wilschut; Sander van Assen; Lolkje T W de Jong van den Berg; Maarten J Postma
Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.
Clinical therapeutics 2010;32(1):133-44.
2010: Petros Pechlivanoglou; Jelle Vehof; Michel van Agthoven; Lolkje T W de Jong van den Berg; Maarten J Postma
Diffusion of a new drug: a comparative analysis of adoption, treatment complexity, and persistence of risperidone long-acting injectable therapy in the Netherlands.
Clinical therapeutics 2010;32(1):108-18.
2010: Cornelis Boersma; Adriaan A Voors; Sipke T Visser; Lolkje T W de Jong van den Berg; Maarten J Postma
Cost effectiveness of angiotensin receptor blocker monotherapy in patients with hypertension in the Netherlands: a comparative analysis using clinical trial and drug utilization data.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2010;10(1):49-54.
2010: Florence van Hunsel; Eugène P van Puijenbroek; Lolkje T W de Jong van den Berg; Kees van Grootheest
Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins.
Pharmacoepidemiology and drug safety 2010;19(1):26-32.
2009: Silvia Ravera; Sylvia A Hummel; Pieter Stolk; Eibert Heerdink; Lolkje T W de Jong van den Berg; Johan J de Gier
The use of driving impairing medicines: a European survey.
European journal of clinical pharmacology 2009;65(11):1139-47.
2009: Josta de Jong; Paul B van den Berg; Sipke T Visser; Tjalling W de Vries; Lolkje T W de Jong van den Berg
Antibiotic usage, dosage and course length in children between 0 and 4 years.
Acta paediatrica (Oslo, Norway : 1992) 2009;98(7):1142-8.
2009: D Joyce Bakker; Lolkje T W de Jong van den Berg; M Rebecca Fokkema
Controlled study on folate status following folic acid supplementation and discontinuation in women of child-bearing age.
Annals of clinical biochemistry 2009;46(Pt 3):231-4.
2009: Anne-Marie Trip; Sipke T Visser; Luuk J Kalverdijk; Lolkje T W de Jong van den Berg
Large increase of the use of psycho-stimulants among youth in the Netherlands between 1996 and 2006.
British journal of clinical pharmacology 2009;67(4):466-8.
2009: Stefan Vegter; Pieternel Kölling; Marjolijn Töben; Sipke T Visser; Lolkje T W de Jong van den Berg
Replacing hormone therapy--is the decline in prescribing sustained, and are nonhormonal drugs substituted?
Menopause (New York, N.Y.) 2009;16(2):329-35.
2008: Jelle Vehof; Maarten J Postma; Richard Bruggeman; Lolkje T W de Jong van den Berg; Paul B Van Den Berg; Ronald P Stolk; Huibert Burger
Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
Journal of clinical psychopharmacology 2008;28(6):625-30.
2008: N W van de Vrie-Hoekstra; Tjalling W de Vries; Paul B van den Berg; O F Brouwer; Lolkje T W de Jong van den Berg
Antiepileptic drug utilization in children from 1997-2005--a study from the Netherlands.
European journal of clinical pharmacology 2008;64(10):1013-20.
2008: Josta de Jong; Paul B van den Berg; Tjalling W de Vries; Lolkje T W de Jong van den Berg
Antibiotic drug use of children in the Netherlands from 1999 till 2005.
European journal of clinical pharmacology 2008;64(9):913-9.
2008: Stefan Vegter; Lolkje T W de Jong van den Berg
Choice of first antihypertensive--comparison between the Irish and Dutch setting.
British journal of clinical pharmacology 2008;66(2):313-5.
2008: Lolkje T W de Jong van den Berg
Monitoring of the folic acid supplementation program in the Netherlands.
Food and nutrition bulletin 2008;29(2 Suppl):S210-3.
2008: Janneke Jentink; Nienke W van de Vrie-Hoekstra; Lolkje T W de Jong van den Berg; Maarten J Postma
Economic evaluation of folic acid food fortification in The Netherlands.
European journal of public health 2008;18(3):270-4.
2008: Luuk J Kalverdijk; Hilde Tobi; Paul B van den Berg; Janelle Buiskool; Leonie Wagenaar; Ruud B Minderaa; Lolkje T W de Jong van den Berg
Use of antipsychotic drugs among Dutch youths between 1997 and 2005.
Psychiatric services (Washington, D.C.) 2008;59(5):554-60.
2008: Cornelis Boersma; Maarten J Postma; Sipke T Visser; Jarir Atthobari; Paul E de Jong; Lolkje T W de Jong van den Berg; Ron T Gansevoort
Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events.
British journal of clinical pharmacology 2008;65(5):723-32.
2008: H E K de Walle; Lolkje T W de Jong van den Berg
Ten years after the Dutch public health campaign on folic acid: the continuing challenge.
European journal of clinical pharmacology 2008;64(5):539-43.
2008: Peter Ter Horst; Frank G A Jansman; Richard A van Lingen; Jan-Pieter Smit; Lolkje T W de Jong van den Berg; Jacobus Brouwers
Pharmacological aspects of neonatal antidepressant withdrawal.
Obstetrical & gynecological survey 2008;63(4):267-79.
2008: Marian K Bakker; Pieternel Kölling; Paul B van den Berg; H E K de Walle; Lolkje T W de Jong van den Berg
Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
British journal of clinical pharmacology 2008;65(4):600-6.
2008: Robin de Vries; Jan E A M van Bergen; Lolkje T W de Jong van den Berg; Maarten J Postma
Cost-utility of repeated screening for Chlamydia trachomatis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2008;11(2):272-4.
2008: Fokaline Vroom; Paul B van den Berg; Lolkje T W de Jong van den Berg
Prescribing of NSAIDs and ASA during pregnancy; do we need to be more careful?
British journal of clinical pharmacology 2008;65(2):275-6.
2008: Joyce de Langen; Florence van Hunsel; Anneke Passier; Lolkje T W de Jong van den Berg; Kees van Grootheest
Adverse drug reaction reporting by patients in the Netherlands: three years of experience.
Drug safety : an international journal of medical toxicology and drug experience 2008;31(6):515-24.
2008: Adrianne Faber; Michel van Agthoven; Luuk J Kalverdijk; Hilde Tobi; Lolkje T W de Jong van den Berg; Lieven Annemans; Maarten J Postma
Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate: a study of cost effectiveness in The Netherlands.
CNS drugs 2008;22(2):157-70.
2008: Robin de Vries; S M G J Daenen; Keith Tolley; Axel Glasmacher; Archie Prentice; Sarah Howells; Hariette Christopherson; Lolkje T W de Jong van den Berg; Maarten J Postma
Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections.
PharmacoEconomics 2008;26(1):75-90.
2008: Fokaline Vroom; Eric N van Roon; Paul B van den Berg; Jacobus Brouwers; Lolkje T W de Jong van den Berg
Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
Pharmacoepidemiology and drug safety 2008;17(1):52-61.
2007: Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong van den Berg
The effect of screening for cardio-renal risk factors on drug use in the general population.
British journal of clinical pharmacology 2007;64(6):810-8.
2007: Juliet M Foster; Thys Van der Molen; Lolkje T W de Jong van den Berg
Patient-reporting of side effects may provide an important source of information in clinical practice.
European journal of clinical pharmacology 2007;63(10):979-80; author reply 981.
2007: Marian K Bakker; H E K de Walle; Aileen Dequito; Paul B van den Berg; Lolkje T W de Jong van den Berg
Selection of controls in case-control studies on maternal medication use and risk of birth defects.
Birth defects research. Part A, Clinical and molecular teratology 2007;79(9):652-6.
2007: Tjalling W de Vries; J J de Langen-Wouterse; Lolkje T W de Jong van den Berg; Eric J Duiverman
Hypertrichosis as a side effect of inhaled steroids in children.
Pediatric pulmonology 2007;42(4):370-3.
2007: Hilde Tobi; Adrianne Faber; Paul B van den Berg; J Wanzer Drane; Lolkje T W de Jong van den Berg
Studying co-medication patterns: the impact of definitions.
Pharmacoepidemiology and drug safety 2007;16(4):405-11.
2007: Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong van den Berg
The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate.
British journal of clinical pharmacology 2007;63(2):224-31.
2007: H E K de Walle; Lolkje T W de Jong van den Berg
Growing gap in folic acid intake with respect to level of education in the Netherlands.
Community genetics 2007;10(2):93-6.
2007: Adrianne Faber; Ron J Keizer; Paul B van den Berg; Lolkje T W de Jong van den Berg; Hilde Tobi
Use of double-blind placebo-controlled N-of-1 trials among stimulant-treated youths in The Netherlands: a descriptive study.
European journal of clinical pharmacology 2007;63(1):57-63.
2006: René Lub; Petra Denig; Paul B van den Berg; Klaas Hoogenberg; Lolkje T W de Jong van den Berg
The impact of new insights and revised practice guidelines on prescribing drugs in the treatment of Type 2 diabetes mellitus.
British journal of clinical pharmacology 2006;62(6):660-5.
2006: D J de Smit; Lolkje T W de Jong van den Berg
[Uncertain effects of folic acid on disorders other than neural-tube defects].
Nederlands tijdschrift voor geneeskunde 2006;150(46):2573; author reply 2573.
2006: Jarir Atthobari; Auke H Brantsma; Ron T Gansevoort; Sipke T Visser; Folkert Asselbergs; Wiek H van Gilst; Paul E de Jong; Lolkje T W de Jong van den Berg
The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(11):3106-14.
2006: Julie M. Zito; Hilde Tobi; Lolkje T W de Jong van den Berg; Jörg M Fegert; Daniel J Safer; Katrin Janhsen; Dorte Gilså Hansen; James F Gardner; Gerd Glaeske
Antidepressant prevalence for youths: a multi-national comparison.
Pharmacoepidemiology and drug safety 2006;15(11):793-8.
2006: Lolkje T W de Jong van den Berg; Marian K Bakker; H E K de Walle; Paul B van den Berg
[The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations].
Nederlands tijdschrift voor geneeskunde 2006;150(40):2222-3.
2006: Willemijn M Meijer; Martha M Werler; Carol Louik; Sonia Hernandez-Diaz; Lolkje T W de Jong van den Berg; Allen A Mitchell
Can folic acid protect against congenital heart defects in Down syndrome?
Birth defects research. Part A, Clinical and molecular teratology 2006;76(10):714-7.
2006: Tessa Ververs; Hans Kaasenbrood; Gerard Visser; Fred Schobben; Lolkje T W de Jong van den Berg; Toine Egberts
Prevalence and patterns of antidepressant drug use during pregnancy.
European journal of clinical pharmacology 2006;62(10):863-70.
2006: Eric Schirm; Tjalling W de Vries; Hilde Tobi; Paul B van den Berg; Lolkje T W de Jong van den Berg
Prescribed doses of inhaled steroids in Dutch children: too little or too much, for too short a time.
British journal of clinical pharmacology 2006;62(4):383-90.
2006: Willemijn M Meijer; Martina C Cornel; Helen Dolk; H E K de Walle; Nicola C Armstrong; Lolkje T W de Jong van den Berg
The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
Pharmacoepidemiology and drug safety 2006;15(9):675-82.
2006: Adrianne Faber; Luuk J Kalverdijk; Lolkje T W de Jong van den Berg; Jacqueline G Hugtenburg; Ruud B Minderaa; Hilde Tobi
Parents report on stimulant-treated children in the Netherlands: initiation of treatment and follow-up care.
Journal of child and adolescent psychopharmacology 2006;16(4):432-40.
2006: Ingrid P C Krapels; Gerhard A Zielhuis; Fokaline Vroom; Lolkje T W de Jong van den Berg; Anne Marie Kuijpers-Jagtman; Aebele B Mink van der Molen; Régine P M Steegers-Theunissen
Periconceptional health and lifestyle factors of both parents affect the risk of live-born children with orofacial clefts.
Birth defects research. Part A, Clinical and molecular teratology 2006;76(8):613-20.
2006: Rogier M Klok; Cornelis Boersma; I Oosterhuis; S T Visser; Lolkje T W de Jong van den Berg; Maarten J Postma
Switch patterns before and after patent expiry of omeprazole: a case study in The Netherlands.
Alimentary pharmacology & therapeutics 2006;23(11):1595-600.
2006: Lolkje T W de Jong van den Berg; Adrianne Faber; Paul B van den Berg
HRT use in 2001 and 2004 in The Netherlands--a world of difference.
Maturitas 2006;54(2):193-7.
2006: Marian K Bakker; J Jentink; Fokaline Vroom; Paul B van den Berg; H E K de Walle; Lolkje T W de Jong van den Berg
Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands.
BJOG : an international journal of obstetrics and gynaecology 2006;113(5):559-68.
2006: Tjalling W de Vries; J J de Langen-Wouterse; E van Puijenbroek; Eric J Duiverman; Lolkje T W de Jong van den Berg
Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands.
European journal of clinical pharmacology 2006;62(5):343-6.
2006: Willemijn M Meijer; Lolkje T W de Jong van den Berg; Marjan D van den Berg; Joke B G M Verheij; H E K de Walle
Clomiphene and hypospadias on a detailed level: signal or chance?
Birth defects research. Part A, Clinical and molecular teratology 2006;76(4):249-52.
2006: Jarir Atthobari; Folkert Asselbergs; Cornelis Boersma; Robin de Vries; Hans L Hillege; Wiek H van Gilst; Ron T Gansevoort; Paul E de Jong; Lolkje T W de Jong van den Berg; Maarten J Postma
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Clinical therapeutics 2006;28(3):432-44.
2006: Fokaline Vroom; H E K de Walle; Mart A J F van de Laar; Jacobus Brouwers; Lolkje T W de Jong van den Berg
Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future.
Drug safety : an international journal of medical toxicology and drug experience 2006;29(10):845-63.
2006: Cornelis Boersma; Jarir Atthobari; Ron T Gansevoort; Lolkje T W de Jong van den Berg; Paul E de Jong; Dick De Zeeuw; Lieven J P Annemans; Maarten J Postma
Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making.
PharmacoEconomics 2006;24(6):523-35.
2006: Robin de Vries; Jan E A M van Bergen; Lolkje T W de Jong van den Berg; Maarten J Postma
Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2006;9(1):1-11.
2006: Tjalling W de Vries; Hilde Tobi; Eric Schirm; Paul van den Berg; Eric J Duiverman; Lolkje T W de Jong van den Berg
The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands.
European journal of clinical pharmacology 2006;62(1):51-5.
2005: Adrianne Faber; Marcel L Bouvy; Linda Loskamp; Paul B van de Berg; Toine Egberts; Lolkje T W de Jong van den Berg
Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.
British journal of clinical pharmacology 2005;60(6):641-7.
2005: Ada G G Stuurman-Bieze; Willem O de Boer; Mirjam E A P Kokenberg; Jacqueline G Hugtenburg; Lolkje T W de Jong van den Berg; Th F J Tromp
Complex pharmaceutical care intervention in pulmonary care: part A. The process and pharmacists' professional satisfaction.
Pharmacy world & science : PWS 2005;27(5):376-84.
2005: Jarir Atthobari; Jasper M Bos; Cornelis Boersma; Jacobus Brouwers; Lolkje T W de Jong van den Berg; Maarten J Postma
Adherence of pharmacoeconomic studies to national guidelines in the Netherlands.
Pharmacy world & science : PWS 2005;27(5):364-70.
2005: Adrianne Faber; Lolkje T W de Jong van den Berg; Karin Netjes; Luuk J Kalverdijk; Ruud B Minderaa; Hilde Tobi
Recruitment of parents and physicians of stimulant-using children via community pharmacies is successful.
Journal of clinical epidemiology 2005;58(10):1072-3.
2005: Martina C Cornel; Denhard J de Smit; Lolkje T W de Jong van den Berg
Folic acid--the scientific debate as a base for public health policy.
Reproductive toxicology (Elmsford, N.Y.) 2005;20(3):411-5.
2005: Willemijn M Meijer; H E K de Walle; Wilhelmina S Kerstjens-Frederikse; Lolkje T W de Jong van den Berg
Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists.
Reproductive toxicology (Elmsford, N.Y.) 2005;20(2):203-7.
2005: Claudia A W Rijcken; H Knegtering; Richard Bruggeman; Hilde Tobi; Lolkje T W de Jong van den Berg
Sex differences in concomitant medication with benzodiazepines or antidepressants in first-break schizophrenic patients treated with antipsychotic medication.
Psychiatry research 2005;134(2):143-50.
2005: Hilde Tobi; Paul B van den Berg; Lolkje T W de Jong van den Berg
Small proportions: what to report for confidence intervals?
Pharmacoepidemiology and drug safety 2005;14(4):239-47.
2005: A C van Grootheest; Lolkje T W de Jong van den Berg
The role of hospital and community pharmacists in pharmacovigilance.
Research in social & administrative pharmacy : RSAP 2005;1(1):126-33.
2005: Adrianne Faber; Lolkje T W de Jong van den Berg; Paul B van den Berg; Hilde Tobi
Psychotropic co-medication among stimulant-treated children in The Netherlands.
Journal of child and adolescent psychopharmacology 2005;15(1):38-43.
2005: Cornelis Boersma; Rogier M Klok; Jasper M Bos; Mark Naunton; Paul B van den Berg; Lolkje T W de Jong van den Berg; Maarten J Postma
Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the Netherlands.
Applied health economics and health policy 2005;4(3):191-6.
2005: Lolkje T W de Jong van den Berg; Sonia Hernandez-Diaz; Martha M Werler; Carol Louik; Allen A Mitchell
Trends and predictors of folic acid awareness and periconceptional use in pregnant women.
American journal of obstetrics and gynecology 2005;192(1):121-8.
2005: Fokaline Vroom; P H de Jong; Paul B van den Berg; Hilde Tobi; Lolkje T W de Jong van den Berg
[Use of oral contraceptives in the years 1994-2002: different but not less].
Nederlands tijdschrift voor geneeskunde 2005;149(1):23-8.
2004: Ada G G Stuurman-Bieze; Paul B van den Berg; Th F J Tromp; Lolkje T W de Jong van den Berg
Computer-assisted medication review for asthmatic patients as a basis for intervention. Constructing and validating an algorithmic computer instrument in pharmacy practice.
Pharmacy world & science : PWS 2004;26(5):289-96.
2004: Dieneke van Driel; Jelle Wesseling; Kirsten ter Huurne; Lya M Geven-Boere; Frits R Rosendaal; Eveline van der Veer; Lolkje T W de Jong van den Berg
Adherence to a guideline for coumarins in pregnancy.
Pharmacy world & science : PWS 2004;26(5):297-300.
2004: Eric Schirm; Lars Pedersen; Hilde Tobi; Gunnar L Nielsen; Henrik T Sørensen; Lolkje T W de Jong van den Berg
Drug use among fathers around time of conception: two register based surveys from Denmark and The Netherlands.
Pharmacoepidemiology and drug safety 2004;13(9):609-13.
2004: Eric Schirm; Hilde Tobi; Lolkje T W de Jong van den Berg
Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children.
Journal of clinical epidemiology 2004;57(7):737-41.
2004: Hilde Tobi; Nico-Jan N van den Heuvel; Lolkje T W de Jong van den Berg
Does uncollected medication reduce the validity of pharmacy dispensing data?
Pharmacoepidemiology and drug safety 2004;13(7):497-500.
2004: Kees van Grootheest; Sten Olsson; Mary Couper; Lolkje T W de Jong van den Berg
Pharmacists' role in reporting adverse drug reactions in an international perspective.
Pharmacoepidemiology and drug safety 2004;13(7):457-64.
2004: Kees van Grootheest; Lolkje T W de Jong van den Berg
Patients' role in reporting adverse drug reactions.
Expert opinion on drug safety 2004;3(4):363-8.
2004: Eric Schirm; Willemijn M Meijer; Hilde Tobi; Lolkje T W de Jong van den Berg
Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system.
European journal of obstetrics, gynecology, and reproductive biology 2004;114(2):182-8.
2004: Kees van Grootheest; Eugène P van Puijenbroek; Lolkje T W de Jong van den Berg
Do pharmacists' reports of adverse drug reactions reflect patients' concerns?
Pharmacy world & science : PWS 2004;26(3):155-9.
2004: Claudia A W Rijcken; Hilde Tobi; A C M Vergouwen; Lolkje T W de Jong van den Berg
Refill rate of antipsychotic drugs: an easy and inexpensive method to monitor patients' compliance by using computerised pharmacy data.
Pharmacoepidemiology and drug safety 2004;13(6):365-70.
2004: Eric Schirm; Taco B M Monster; Robin de Vries; Paul B van den Berg; Lolkje T W de Jong van den Berg; Hilde Tobi
How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information.
Pharmacoepidemiology and drug safety 2004;13(3):173-9.
2004: Eric Schirm; Hilde Tobi; Eugène P van Puijenbroek; Margje H Monster-Simons; Lolkje T W de Jong van den Berg
Reported adverse drug reactions and their determinants in Dutch children outside the hospital.
Pharmacoepidemiology and drug safety 2004;13(3):159-65.
2004: Jarir Atthobari; Taco B M Monster; Paul E de Jong; Lolkje T W de Jong van den Berg
The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs.
British journal of clinical pharmacology 2004;57(3):328-36.
2004: Eric Schirm; M P Schwagermann; Hilde Tobi; Lolkje T W de Jong van den Berg
Drug use during breastfeeding. A survey from the Netherlands.
European journal of clinical nutrition 2004;58(2):386-90.
2004: Karen N van Dijk; Arian W Plat; Alieke A C van Dijk; Margriet Piersma-Wichers; Anne M B de Vries-Bots; Jennita Slomp; Lolkje T W de Jong van den Berg; Jacobus Brouwers
Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
Thrombosis and haemostasis 2004;91(1):95-101.
2003: Eric Schirm; Hilde Tobi; Tjalling W de Vries; I Choonara; Lolkje T W de Jong van den Berg
Lack of appropriate formulations of medicines for children in the community.
Acta paediatrica (Oslo, Norway : 1992) 2003;92(12):1486-9.
2003: Claudia A W Rijcken; Taco B M Monster; Jacobus Brouwers; Lolkje T W de Jong van den Berg
Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?
Journal of clinical psychopharmacology 2003;23(6):657-9.
2003: Hilde Tobi; Willemijn M Meijer; Jolanda Tuinstra; Lolkje T W de Jong van den Berg
Socio-economic differences in prescription and OTC drug use in Dutch adolescents.
Pharmacy world & science : PWS 2003;25(5):203-6.
2003: Evelyn S Schaafsma; Theo Raynor; Lolkje T W de Jong van den Berg
Accessing medication information by ethnic minorities: barriers and possible solutions.
Pharmacy world & science : PWS 2003;25(5):185-90.
2003: Hilde Tobi; Paul B van den Berg; Jacobus Brouwers; Lolkje T W de Jong van den Berg
[Hormone replacement therapy in the peri-menopausal and post menopausal period: more than half of the women were treated for more than one year].
Nederlands tijdschrift voor geneeskunde 2003;147(38):1853-5.
2003: Claudia A W Rijcken; G J Boelema; C J Slooff; P J Beuger; T A Tanja; Lolkje T W de Jong van den Berg
Off-label use of antipsychotics in the community pharmacy: the sex differences.
Pharmacopsychiatry 2003;36(5):187-91.
2003: AC van Grootheest; J K Groote; Lolkje T W de Jong van den Berg
Intensive monitoring of new drugs based on first prescription signals from pharmacists: a pilot study.
Pharmacoepidemiology and drug safety 2003;12(6):475-81.
2003: Maarten J Postma; Hanneke Kruidhof; Lolkje T W de Jong van den Berg; Dick De Zeeuw
Pharmacoeconomic aspects of losartan treatment to delay progression of renal disease in patients with Type 2 diabetes.
Expert opinion on pharmacotherapy 2003;4(9):1543-50.
2003: Karen N van Dijk; Lisa G Pont; Corinne S de Vries; Maria Franken; Jacobus Brouwers; Lolkje T W de Jong van den Berg
Prescribing indicators for evaluating drug use in nursing homes.
The Annals of pharmacotherapy 2003;37(7-8):1136-41.
2003: Karin M van der Pal-de Bruin; H E K de Walle; Carolien M de Rover; Wendy Jeeninga; Martina C Cornel; Lolkje T W de Jong van den Berg; Simone E Buitendijk; Theo G W M Paulussen
Influence of educational level on determinants of folic acid use.
Paediatric and perinatal epidemiology 2003;17(3):256-63.
2003: Jeroen C F de Jong; Paul B van den Berg; Hilde Tobi; Lolkje T W de Jong van den Berg
Combined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effects.
British journal of clinical pharmacology 2003;55(6):591-5.
2003: Marc Weeber; Rein Vos; Henny Klein; Lolkje T W de Jong van den Berg; Alan R Aronson; Grietje Molema
Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide.
Journal of the American Medical Informatics Association : JAMIA 2003;10(3):252-9.
2003: Maarten J Postma; Eduard J Beck; Herman G Sprenger; Lolkje T W de Jong van den Berg
The economic profile of antenatal HIV testing: pharmaceutical and methodological considerations.
AIDS (London, England) 2003;17(5):755-7.
2003: Taco B M Monster; Paul E de Jong; Lolkje T W de Jong van den Berg
Drug-induced renal function impairment: a population-based survey.
Pharmacoepidemiology and drug safety 2003;12(2):135-43.
2003: Eric Schirm; Hilde Tobi; Lolkje T W de Jong van den Berg
Risk factors for unlicensed and off-label drug use in children outside the hospital.
Pediatrics 2003;111(2):291-5.
2003: Lolkje T W de Jong van den Berg; Hilde Tobi; Bert Bijker; Paul van den Berg
Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study.
BMJ (Clinical research ed.) 2003;326(7383):254.
2003: Kees van Grootheest; Linda de Graaf; Lolkje T W de Jong van den Berg
Consumer adverse drug reaction reporting: a new step in pharmacovigilance?
Drug safety : an international journal of medical toxicology and drug experience 2003;26(4):211-7.
2002: KN van Dijk; CS de Vries; K ter Huurne; Paul B van den Berg; Jacobus Brouwers; Lolkje T W de Jong van den Berg
Concomitant prescribing of benzodiazepines during antidepressant therapy in the elderly.
Journal of clinical epidemiology 2002;55(10):1049-53.
2002: Roel Fijn; L Sara van Epenhuysen; A Jeanne M Peijnenburg; Lolkje T W de Jong van den Berg; Jacobus Brouwers
Introducing ethics in hospital drug resource allocation decisions: keep expectations modest and beware of unintended effects. Part II: The use of ethics.
Pharmacoepidemiology and drug safety 2002;11(7):617-20.
2002: Eric Schirm; Hilde Tobi; Lolkje T W de Jong van den Berg
Low use of medication in home deliveries in the Netherlands.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2002;79(1):5-9.
2002: Roel Fijn; L Sara van Epenhuysen; A Jeanne M Peijnenburg; Lolkje T W de Jong van den Berg; Jacobus Brouwers
Introducing ethics in hospital drug resource allocation decisions: keep expectations modest and beware of unintended effects. Part I: An explorative overview.
Pharmacoepidemiology and drug safety 2002;11(6):523-7.
2002: Eric Schirm; Hilde Tobi; Henkjan Gebben; Lolkje T W de Jong van den Berg
Anti-asthmatic drugs and dosage forms in children: a cross-sectional study.
Pharmacy world & science : PWS 2002;24(4):162-5.
2002: Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong van den Berg
Pharmacy data in epidemiological studies: an easy to obtain and reliable tool.
Pharmacoepidemiology and drug safety 2002;11(5):379-84.
2002: Roel Fijn; Man-Chie Chow; Pauline M H Schuur; Lolkje T W de Jong van den Berg; Jacobus Brouwers
Multicentre evaluation of prescribing concurrence with anti-infective guidelines: epidemiological assessment of indicators.
Pharmacoepidemiology and drug safety 2002;11(5):361-72.
2002: H E K de Walle; Lolkje T W de Jong van den Berg
Insufficient folic acid intake in the Netherlands: what about the future?
Teratology 2002;66(1):40-3.
2002: H E K de Walle; Martina C Cornel; Lolkje T W de Jong van den Berg
Three years after the dutch folic acid campaign: growing socioeconomic differences.
Preventive medicine 2002;35(1):65-9.
2002: Maarten J Postma; J J Kwik; W J M J Rutten; Lolkje T W de Jong van den Berg; Jacobus Brouwers
[Agreement between guidelines for pharmaco-economic research and never-before-published health-economics evaluations].
Nederlands tijdschrift voor geneeskunde 2002;146(23):1082-7.
2002: KN van Dijk; K ter Huurne; CS de Vries; Paul B van den Berg; Jacobus Brouwers; Lolkje T W de Jong van den Berg
Prescribing of gastroprotective drugs among elderly NSAID users in The Netherlands.
Pharmacy world & science : PWS 2002;24(3):100-3.
2002: Eric Schirm; Hilde Tobi; Lolkje T W de Jong van den Berg
Unlicensed and off label drug use by children in the community: cross sectional study.
BMJ (Clinical research ed.) 2002;324(7349):1312-3.
2002: Maarten J Postma; Jasper M Bos; Lolkje T W de Jong van den Berg; Andrea Tramarin; Jan E A M van Bergen
HIV post-exposure prophylaxis: enhancing its pharmaco-economic profile by discriminate prescribing.
AIDS (London, England) 2002;16(8):1177-9.
2002: Rogier M Klok; Jacobus Brouwers; Paul B van den Berg; Lolkje T W de Jong van den Berg; K Tolley; Maarten J Postma
Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugs.
Alimentary pharmacology & therapeutics 2002;16(5):1033-4.
2002: Roel Fijn; L Sara van Epenhuysen; A Jeanne M Peijnenburg; Jacobus Brouwers; Lolkje T W de Jong van den Berg
Is there a need for critical ethical and philosophical evaluation of hospital drugs and therapeutics (D&T) committees?
Pharmacoepidemiology and drug safety 2002;11(3):247-52.
2002: AC van Grootheest; Eugène P van Puijenbroek; Lolkje T W de Jong van den Berg
Contribution of pharmacists to the reporting of adverse drug reactions.
Pharmacoepidemiology and drug safety 2002;11(3):205-10.
2002: Roel Fijn; Patricia Van den Bemt; M Chow; C J De Blaey; Lolkje T W de Jong van den Berg; Jacobus Brouwers
Hospital prescribing errors: epidemiological assessment of predictors.
British journal of clinical pharmacology 2002;53(3):326-31.
2002: Maarten J Postma; J Londeman; M Veenstra; H E K de Walle; Lolkje T W de Jong van den Berg
Cost-effectiveness of periconceptional supplementation of folic acid.
Pharmacy world & science : PWS 2002;24(1):8-11.
2002: Jennita Reefhuis; Lolkje T W de Jong van den Berg; Martina C Cornel
The use of birth defect registries for etiological research: a review.
Community genetics 2002;5(1):13-32.
2002: Maarten J Postma; Paul Jansema; Marianne L L van Genugten; Marie-Louise A Heijnen; Johannes C Jager; Lolkje T W de Jong van den Berg
Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
Drugs 2002;62(7):1013-24.
2002: Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong van den Berg
The impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population.
British journal of clinical pharmacology 2002;53(1):31-6.
2002: Jørn Olsen; Andrew E Czeizel; Henrik Toft Sørensen; Gunnar Lauge Nielsen; Lolkje T W de Jong van den Berg; Lorentz M Irgens; Charlotte Olesen; Lars Pedersen; Helle Larsen; Rolv T Lie; Corinne S de Vries; Ulf Bergman
How do we best detect toxic effects of drugs taken during pregnancy? A EuroMap paper.
Drug safety : an international journal of medical toxicology and drug experience 2002;25(1):21-32.
2001: Claudia A W Rijcken; J A Dekens-Konter; H Knegtering; Lolkje T W de Jong van den Berg
Reporting sexual function disorders caused by antipsychotic drugs: is there a role for the community pharmacy?
Pharmacy world & science : PWS 2001;23(5):169-72.
2001: Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong van den Berg
Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria.
Archives of internal medicine 2001;161(16):2000-5.
2001: Charlotte Olesen; Chris Søndergaard; Nana Thrane; Gunnar Lauge Nielsen; Lolkje T W de Jong van den Berg; Jørn Olsen
Do pregnant women report use of dispensed medications?
Epidemiology (Cambridge, Mass.) 2001;12(5):497-501.
2001: Eric Schirm; Hilde Tobi; Julie M. Zito; Lolkje T W de Jong van den Berg
Psychotropic medication in children: a study from the Netherlands.
Pediatrics 2001;108(2):E25.
2000: Eric Schirm; Henkjan Gebben; Hilde Tobi; Lolkje T W de Jong van den Berg
[Deptropine still prescribed for 0-4 year olds].
Nederlands tijdschrift voor geneeskunde 2000;144(50):2409-11.
2000: Maarten J Postma; A Bakker; Robert Welte; Jan E A M van Bergen; J A R van den Hoek; Lolkje T W de Jong van den Berg; Johannes C Jager
[Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
Nederlands tijdschrift voor geneeskunde 2000;144(49):2350-4.
2000: Roel Fijn; Ada G G Stuurman-Bieze; Paul B van den Berg; Jacobus Brouwers; Pieter A de Graeff; Lolkje T W de Jong van den Berg
Predictors for prophylactic antithrombotic prescribing in ischaemic heart disease and the impact of national guidelines.
European journal of clinical pharmacology 2000;56(9-10):739-46.
2000: Eric Schirm; Paul van den Berg; Henkjan Gebben; P Sauer; Lolkje T W de Jong van den Berg
Drug use of children in the community assessed through pharmacy dispensing data.
British journal of clinical pharmacology 2000;50(5):473-8.
2000: Maarten J Postma; Eduard J Beck; C A Hankins; Sundhiya Mandalia; Johannes C Jager; Lolkje T W de Jong van den Berg; M D Walters; L Sherr
Cost effectiveness of expanded antenatal HIV testing in London.
AIDS (London, England) 2000;14(15):2383-9.
2000: Roel Fijn; Jacobus Brouwers; JW Timmer; Lolkje T W de Jong van den Berg
Rational pharmacotherapy and clinical practice guidelines. Theories and perspectives on implementing pharmacotherapeutic treatment guidelines.
Pharmacy world & science : PWS 2000;22(4):152-8.
2000: Jennita Reefhuis; H E K de Walle; Lolkje T W de Jong van den Berg; Martina C Cornel
Additional information from parental questionnaires and pharmacy records for registration of birth defects. EuroMAP-group.
European journal of epidemiology 2000;16(4):329-36.
2000: Karin M van der Pal-de Bruin; H E K de Walle; Wendy Jeeninga; Carolien M de Rover; Martina C Cornel; Lolkje T W de Jong van den Berg; Jan Schouten; Ronald Brand; Simone E Buitendijk
The Dutch 'Folic Acid Campaign'--have the goals been achieved?
Paediatric and perinatal epidemiology 2000;14(2):111-7.
2000: Patricia Van den Bemt; Toine Egberts; Lolkje T W de Jong van den Berg; Jacobus Brouwers
Drug-related problems in hospitalised patients.
Drug safety : an international journal of medical toxicology and drug experience 2000;22(4):321-33.
2000: Roel Fijn; S A Engels; Jacobus Brouwers; R J Knaap; Lolkje T W de Jong van den Berg
Dutch hospital drug formularies: pharmacotherapeutic variation and conservatism, but concurrence with national pharmacotherapeutic guidelines.
British journal of clinical pharmacology 2000;49(3):254-63.
2000: Marc Weeber; H Klein; Alan R Aronson; James G Mork; Lolkje T W de Jong van den Berg; Rein Vos
Text-based discovery in biomedicine: the architecture of the DAD-system.
Proceedings / AMIA ... Annual Symposium. AMIA Symposium 2000;():903-7.
2000: KN van Dijk; CS de Vries; Paul B van den Berg; Jacobus Brouwers; Lolkje T W de Jong van den Berg
Drug utilisation in Dutch nursing homes.
European journal of clinical pharmacology 2000;55(10):765-71.
1999: JW Timmer; P A de Smet; Jan Schuling; Th F J Tromp; Lolkje T W de Jong van den Berg
Patient education to users of oral hypoglycemic agents: the perspective of Dutch community pharmacists.
Pharmacy world & science : PWS 1999;21(5):200-4.
1999: G Ijben; Foppe van Mil; Th F J Tromp; Lolkje T W de Jong van den Berg
Quantification of communication processes, is it possible?
Pharmacy world & science : PWS 1999;21(5):195-9.
1999: H E K de Walle; Martina C Cornel; Denhard J de Smit; Lolkje T W de Jong van den Berg
Preconceptional use of folic acid amongst women of advanced maternal age.
Prenatal diagnosis 1999;19(10):996-7.
1999: CS de Vries; C A Duggan; Th F J Tromp; Lolkje T W de Jong van den Berg
Changing prescribing in the light of tolerability concerns: how is this best achieved?
Drug safety : an international journal of medical toxicology and drug experience 1999;21(3):153-60.
1999: Charlotte Olesen; Henrik Toft Sørensen; Lolkje T W de Jong van den Berg; Jørn Olsen; FH Steffensen
Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. The Euromap Group.
Acta obstetricia et gynecologica Scandinavica 1999;78(8):686-92.
1999: Roel Fijn; Jacobus Brouwers; R J Knaap; Lolkje T W de Jong van den Berg
Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.
British journal of clinical pharmacology 1999;48(2):239-46.
1999: H E K de Walle; KM van der Pal; Lolkje T W de Jong van den Berg; Wendy Jeeninga; J S Schouten; Carolien M de Rover; Simone E Buitendijk; Martina C Cornel
Effect of mass media campaign to reduce socioeconomic differences in women's awareness and behaviour concerning use of folic acid: cross sectional study.
BMJ (Clinical research ed.) 1999;319(7205):291-2.
1999: Lolkje T W de Jong van den Berg; N Feenstra; H T Sorensen; M C Cornel
Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. Europen Medicine and Pregnancy Group.
Teratology 1999;60(1):33-6.
1999: Roel Fijn; CS de Vries; S A Engels; Jacobus Brouwers; C J de Blaey; Lolkje T W de Jong van den Berg
The quality of Dutch hospital drug formularies: evaluation of technical features and organisational information.
Pharmacy world & science : PWS 1999;21(3):120-6.
1999: Foppe van Mil; D F Tromp; J C McElnay; Lolkje T W de Jong van den Berg; R Vos
Development of pharmaceutical care in The Netherlands: pharmacy's contemporary focus on the patient.
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) 1999;39(3):395-401.
1999: CS de Vries; Paul B van den Berg; JW Timmer; A Reicher; W Blijleven; Th F J Tromp; Lolkje T W de Jong van den Berg
Prescription data as a tool in pharmacotherapy audit (II). The development of an instrument.
Pharmacy world & science : PWS 1999;21(2):85-90.
1999: CS de Vries; Th F J Tromp; W Blijleven; Lolkje T W de Jong van den Berg
Prescription data as a tool in pharmacotherapy audit (I). General considerations.
Pharmacy world & science : PWS 1999;21(2):80-4.
1999: Roel Fijn; Lolkje T W de Jong van den Berg; Jacobus Brouwers
Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitals.
Pharmacy world & science : PWS 1999;21(2):74-9.
1999: Charlotte Olesen; FH Steffensen; Gunnar Lauge Nielsen; Lolkje T W de Jong van den Berg; Jørn Olsen; Henrik Toft Sørensen
Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group.
European journal of clinical pharmacology 1999;55(2):139-44.
1998: H E K de Walle; KM van der Pal; Lolkje T W de Jong van den Berg; Jan Schouten; Carolien M de Rover; Simone E Buitendijk; Martina C Cornel
Periconceptional folic acid in The Netherlands in 1995. Socioeconomic differences.
Journal of epidemiology and community health 1998;52(12):826-7.
1998: Lolkje T W de Jong van den Berg; J Rutgers; Martina C Cornel
[Thalidomide once more in the spotlight].
Nederlands tijdschrift voor geneeskunde 1998;142(46):2509-12.
1998: KN van Dijk; CS de Vries; Paul B van den Berg; A M Dijkema; Jacobus Brouwers; Lolkje T W de Jong van den Berg
Constipation as an adverse effect of drug use in nursing home patients: an overestimated risk.
British journal of clinical pharmacology 1998;46(3):255-61.
1998: Lolkje T W de Jong van den Berg; H E K de Walle; Karin M van der Pal-de Bruin; Simone E Buitendijk; Martina C Cornel
Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from 1994 to 1995.
European journal of clinical pharmacology 1998;54(4):329-31.
1997: Henrik Toft Sørensen; Lolkje T W de Jong van den Berg
Pharmacoepidemiological studies in pregnancy: the need for international collaboration.
The International journal of risk & safety in medicine 1997;10(3):193-5.
1996: A L den Quden; Remy A HiraSing; Simone E Buitendijk; Lolkje T W de Jong van den Berg; H E K de Walle; Martina C Cornel
[Prevalence, clinical aspects and prognosis of neural tube defects in The Netherlands].
Nederlands tijdschrift voor geneeskunde 1996;140(42):2092-5.
1996: Martina C Cornel; H E K de Walle; Lolkje T W de Jong van den Berg
[Regular vitamin A supplements are safe for pregnant women who consume few liver products].
Nederlands tijdschrift voor geneeskunde 1996;140(12):679-80.
1996: CS de Vries; N M van Diepen; Th F J Tromp; Lolkje T W de Jong van den Berg
Auditing GPs' prescribing habits: cardiovascular prescribing frequently continues medication initiated by specialists.
European journal of clinical pharmacology 1996;50(5):349-52.
1995: Lolkje T W de Jong van den Berg; Martina C Cornel; T Tymstra; Simone E Buitendijk
Folate prophylaxis in pregnancy.
Lancet 1995;346(8984):1227-8.
1995: A M van Trigt; Lolkje T W de Jong van den Berg; L M Voogt; J Willems; Th F J Tromp; Flora M Haaijer-Ruskamp
Setting the agenda: does the medical literature set the agenda for articles about medicines in the newspapers?
Social science & medicine (1982) 1995;41(6):893-9.
1995: M C Sturkenboom; A Middelbeek; Lolkje T W de Jong van den Berg; Paul B van den Berg; B H Stricker; H Wesseling
Vulvo-vaginal candidiasis associated with acitretin.
Journal of clinical epidemiology 1995;48(8):991-7.
1995: M C Sturkenboom; B H Stricker; Lolkje T W de Jong van den Berg; Martina C Cornel; H Wesseling
The role of pharmacists in the recruitment of a cohort for postmarketing surveillance. A case study of acitretin in The Netherlands.
Pharmacy world & science : PWS 1995;17(4):126-32.
1995: A M Van Trigt; Flora M Haaijer-Ruskamp; Lolkje T W de Jong van den Berg
Reporting research in medical journals and newspapers.
BMJ (Clinical research ed.) 1995;311(6996):62.
1995: A M van Trigt; Lolkje T W de Jong van den Berg; M Pasman; Flora M Haaijer-Ruskamp; J Willems; Th F J Tromp
Information about drugs in family magazines.
Pharmacy world & science : PWS 1995;17(2):48-53.
1994: A M van Trigt; C M Waardenburg; Flora M Haaijer-Ruskamp; Lolkje T W de Jong van den Berg
Questions about drugs: how do pregnant women solve them?
Pharmacy world & science : PWS 1994;16(6):254-9.
1994: M C Sturkenboom; Lolkje T W de Jong van den Berg; P C van Voorst-Vader; Martina C Cornel; B H Stricker; H Wesseling
Inability to detect plasma etretinate and acitretin is a poor predictor of the absence of these teratogens in tissue after stopping acitretin treatment.
British journal of clinical pharmacology 1994;38(3):229-35.
1994: A M van Trigt; Lolkje T W de Jong van den Berg; Flora M Haaijer-Ruskamp; J Willems; Th F J Tromp
Journalists and their sources of ideas and information on medicines.
Social science & medicine (1982) 1994;38(4):637-43.
1994: M C Sturkenboom; Lolkje T W de Jong van den Berg; Martina C Cornel; B H Stricker; H Wesseling
Communicating a drug alert. A case study on acitretin in The Netherlands.
European journal of clinical pharmacology 1994;47(2):125-32.
1993: Martina C Cornel; Lolkje T W de Jong van den Berg; R P Steegers-Theunissen; Leo P ten Kate
[Folic acid for all fertile women?].
Nederlands tijdschrift voor geneeskunde 1993;137(26):1283-5.
1993: L E Visser; M H Oosterveld; G I Vos; Lolkje T W de Jong van den Berg
Drug-utilization study on Curaçao.
Pharmacy world & science : PWS 1993;15(2):73-8.
1993: Lolkje T W de Jong van den Berg; C M Waardenburg; Flora M Haaijer-Ruskamp; M N Dukes; H Wesseling
Drug use in pregnancy: a comparative appraisal of data collecting methods.
European journal of clinical pharmacology 1993;45(1):9-14.
1992: G J Knijn; Martina C Cornel; Lolkje T W de Jong van den Berg; P A de Smet
[Teratogenic risks of high-dosage vitamin A].
Nederlands tijdschrift voor geneeskunde 1992;136(42):2060-5.
1992: Lolkje T W de Jong van den Berg; Paul B van den Berg; Flora M Haaijer-Ruskamp; M N Dukes; H Wesseling
Handling of risk-bearing drugs during pregnancy. Do we choose less risky alternatives?
Pharmaceutisch weekblad. Scientific edition 1992;14(2):38-45.
1992: M L Bouvy; M C Sturkenboom; Martina C Cornel; Lolkje T W de Jong van den Berg; B H Stricker; H Wesseling
Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways.
Pharmaceutisch weekblad. Scientific edition 1992;14(2):33-7.
1992: B H Stricker; M Barendregt; Ron Herings; Lolkje T W de Jong van den Berg; Martina C Cornel; P A de Smet
Ad hoc tracing of a cohort of patients exposed to acitretine (Neotigason) on a nation-wide scale.
European journal of clinical pharmacology 1992;42(5):555-7.
1991: B H Stricker; M Barendregt; Ron Herings; Lolkje T W de Jong van den Berg; Martina C Cornel; P A de Smet
[Acitretin; an example of ad-hoc tracing of users in acute problems with drugs].
Nederlands tijdschrift voor geneeskunde 1991;135(21):934-7.
1991: Lolkje T W de Jong van den Berg; Paul B van den Berg; Flora M Haaijer-Ruskamp; M N Dukes; H Wesseling
Investigating drug use in pregnancy. Methodological problems and perspectives.
Pharmaceutisch weekblad. Scientific edition 1991;13(1):32-8.
1991: Flora M Haaijer-Ruskamp; Lolkje T W de Jong van den Berg
Drug utilization studies and drug monitoring in The Netherlands.
Annali dell'Istituto superiore di sanità 1991;27(2):217-23.
1990: Martina C Cornel; Lolkje T W de Jong van den Berg; J Koudstaal; M A Wiegerinck; Gerard te Meerman; Leo P ten Kate
[Indications for an increased risk of neural tube defects in pregnancies following ovulation induction and (or) in-vitro fertilization].
Nederlands tijdschrift voor geneeskunde 1990;134(28):1357-61.